Elite Diagnostic Valuation

Is ELITE undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of ELITE when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate ELITE's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate ELITE's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for ELITE?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for ELITE. This is calculated by dividing ELITE's market cap by their current preferred multiple.
What is ELITE's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	JA$643.19m

ELITE key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.3x
Enterprise Value/EBITDA	5.3x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does ELITE's PE Ratio compare to its peers?

The above table shows the PE ratio for ELITE vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	16.6x
IPCL Image Plus Consultants	11.7x	n/a	JA$2.1b
RAWILL R.A. Williams Distributors	21.7x	n/a	JA$1.8b
INDIES Indies Pharma Jamaica	19.5x	n/a	JA$4.2b
PHSC PHSC	13.6x	n/a	UK£3.4m
ELITE Elite Diagnostic	24.6x	n/a	JA$643.2m

Price-To-Earnings vs Peers: ELITE is expensive based on its Price-To-Earnings Ratio (24.6x) compared to the peer average (16.6x).

Price to Earnings Ratio vs Industry

How does ELITE's PE Ratio compare vs other companies in the Global Healthcare Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	28.1%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	28.1%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: ELITE is expensive based on its Price-To-Earnings Ratio (24.6x) compared to the Global Healthcare industry average (22.9x).

Price to Earnings Ratio vs Fair Ratio

What is ELITE's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

ELITE PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	24.6x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate ELITE's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.